US Patent

US8387612 — Self-contained heating unit and drug-supply unit employing same

Formulation · Assigned to Alexza Pharmaceuticals Inc · Expires 2026-10-23 · 0y remaining

Vulnerability score 65/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a self-contained heating unit and drug-supply unit that rapidly heats a drug to a vapor.

USPTO Abstract

Heating units, drug supply units and drug delivery articles capable of rapid heating are disclosed. Heating units comprising a substrate and a solid fuel capable of undergoing an exothermic metal oxidation reaction disposed within the substrate are disclosed. These heating units can be actuated by electrical resistance, by optical ignition or by percussion. Drug supply units and drug delivery articles wherein a solid fuel is configured to heat a substrate to a temperature sufficient to rapidly thermally vaporize a drug disposed thereon are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
US8387612
Jurisdiction
US
Classification
Formulation
Expires
2026-10-23
Drug substance claim
No
Drug product claim
Yes
Assignee
Alexza Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.